Bleeding problems in the newborn infant.
D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D001238:Asphyxia Neonatorum / Q000150:complications; D001323:Autoantibodies; D001327:Autoimmune Diseases; D001778:Blood Coagulation Disorders / Q000209:etiology; D001803:Blood Transfusion; D004211:Disseminated Intravascular Coagulation / Q000150:complications / Q000188:drug therapy; D005167:Factor VII / Q000096:biosynthesis; D005260:Female; D006487:Hemostasis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000209:etiology; D007234:Infant, Premature; D008099:Liver / Q000378:metabolism; D008107:Liver Diseases / Q000150:complications; D011247:Pregnancy; D012127:Respiratory Distress Syndrome, Newborn / Q000150:complications; D012771:Shock, Hemorrhagic / Q000628:therapy; D013921:Thrombocytopenia / Q000209:etiology / Q000235:genetics; D014777:Virus Diseases / Q000150:complications
D000925:Anticoagulants; D000927:Anticonvulsants; D001323:Autoantibodies; D005167:Factor VII; D006493:Heparin